IASO-782 in Autoimmune Hematological Diseases
Phase 1
Not yet recruiting
- Conditions
- Warm Autoimmune Haemolytic AnaemiaAutoimmune Thrombocytopenia
- Interventions
- Drug: IASO-782 injectionDrug: placebo
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Shanghai IASO Biotechnology Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT06534021
© Copyright 2025. All Rights Reserved by MedPath